{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:46:01Z","timestamp":1787165161935,"version":"build-2736575974"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CIRCB","award":["Annual budget 2017"],"award-info":[{"award-number":["Annual budget 2017"]}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["CDF-TMA 1027"],"award-info":[{"award-number":["CDF-TMA 1027"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235958","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T14:20:46Z","timestamp":1595341246000},"page":"e0235958","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-2763","authenticated-orcid":true,"given":"Joseph","family":"Fokam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desire","family":"Takou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Teto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu E.","family":"Nforbih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odine P.","family":"Kome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezechiel S.","family":"Ngoufack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbuh","family":"Eyongetah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella T.","family":"Fokunang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Fokunang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Colizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo-Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ndjolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"pone.0235958.ref001","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"FJ Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"pone.0235958.ref002","unstructured":"United Nations. On the fast-track to ending the AIDS epidemic. Available at: http:\/\/sgreport.unaids.org\/pdf\/20160423_SGreport_HLM_en.pdf. Accessed 7 June 2016."},{"key":"pone.0235958.ref003","unstructured":"UNAIDS. Fast-track: ending the AIDS epidemic by 2030. Available at: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2686_WAD2014report_en.pdf. Accessed 6 June 2016."},{"key":"pone.0235958.ref004","unstructured":"World Health Organisation: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva 2016. Available at: http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/en"},{"issue":"4","key":"pone.0235958.ref005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/aid.2015.0065","article-title":"Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines","volume":"32","author":"J Fokam","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0235958.ref006","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1128\/AAC.48.8.2993-2998.2004","article-title":"Nucleotide and amino acid polymorphisms at drug resistance sites in non- B-subtype variants of human immunodeficiency virus type 1","volume":"48","author":"D Turner","year":"2004","journal-title":"Antilmicro Agents and Chemother"},{"key":"pone.0235958.ref007","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1086\/427212","article-title":"Prevalence of Antiretroviral Drug resistance Mutations in chronically HIV-infected treatment Na\u00efve patients: implications for Routine Resistance Screening before Initiation of Antietroviral therapy. Community Programs for Clinical Research on AIDS 058 study Team","volume":"40","author":"RM Novak","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0235958.ref008","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management","volume":"192","author":"AMJ Wensing","year":"2005","journal-title":"J Infect Dis"},{"key":"pone.0235958.ref009","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jmv.20881","article-title":"Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile","volume":"79","author":"M Rios","year":"2007","journal-title":"J Med Virol"},{"key":"pone.0235958.ref010","volume-title":"HIV drug resistance report 2017","year":"2017"},{"key":"pone.0235958.ref011","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0924-8579(00)00270-3","article-title":"Resistance to antiretroviral drugs in patients with primary infection","volume":"16","author":"BG Brenner","year":"2000","journal-title":"Inter J Antimicro Agents"},{"key":"pone.0235958.ref012","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00126334-200103010-00010","article-title":"Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-na\u00efve patients of the German seroconverter study","volume":"26","author":"S Duwe","year":"2001","journal-title":"JAcquir Immune Defic Syndr"},{"key":"pone.0235958.ref013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV","volume":"347","author":"SJ Little","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0235958.ref014","doi-asserted-by":"crossref","first-page":"e1001810","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and SequenceLevel Meta-Analysis","volume":"12","author":"S-Y Rhee","year":"2015","journal-title":"PLoS Med"},{"issue":"5","key":"pone.0235958.ref015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/ijerph5050378","article-title":"Current Status of HIV\/AIDS in Cameroon: How Effective are Control Strategies?","volume":"5","author":"D Mbanya","year":"2008","journal-title":"Int J Environ Res Public Health"},{"key":"pone.0235958.ref016","unstructured":"CAMEROON Country Operational Plan COP 2017 Strategic Direction Summary April 17, 2017"},{"key":"pone.0235958.ref017","unstructured":"Dermographic and Health Survey report. Yaounde, Cameroon; 2011."},{"issue":"2","key":"pone.0235958.ref018","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jmv.21677","article-title":"HIV-1 Reverse Transcriptase Drug-Resistance Mutations in Chronically Infected Individuals Receiving or Na\u00efve to HAART in Cameroon","volume":"82","author":"T Sherri","year":"2010","journal-title":"J Med Virol"},{"issue":"3","key":"pone.0235958.ref019","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jmv.23846","article-title":"The Evolution of HIV-1 group M Genetic Variability in Southern Cameroon is characterized by Several Emerging Recombinant Forms of CRF02_AG and viruses with drug resistance mutations","volume":"86","author":"L Agyingi","year":"2014","journal-title":"J Med Virol"},{"key":"pone.0235958.ref020","article-title":"Report of the first semester activities for the fight against HIV\/AIDS in Cameroon","author":"MoPH Cameroon","year":"2011"},{"key":"pone.0235958.ref021","unstructured":"National AIDS Control Committee: National Report on Monitoring of the Political Declaration on HIV\/AIDS\/Cameroon Global Aids Response Progress (GARP), p.18, Yaounde. 2015. Accessed on August 15, 2015 at http:\/\/www.cnls.cm\/docs\/Rapport_GARP_2014_Juin_2015_CNLS.pdf"},{"issue":"5","key":"pone.0235958.ref022","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/jmv.23244","article-title":"Characterization of drug resistance mutations in na\u00efve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon","volume":"84","author":"L Ceccarelli","year":"2012","journal-title":"J Med Virol"},{"key":"pone.0235958.ref023","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/135965350601100511","article-title":"HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon","volume":"11","author":"L Vergne","year":"2006","journal-title":"Antivir Ther"},{"key":"pone.0235958.ref024","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.qai.0000209909.20373.3b","article-title":"HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug-naive pregnant women in Yaounde \u00b4, Cameroon","volume":"42","author":"A Vessiere","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0235958.ref025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/JCM.00428-07","article-title":"Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of major drug-resistance mutations in newly diagnosed patients infected with subtypes other than subtype B","volume":"46","author":"N Ndembi","year":"2008","journal-title":"J Clin Microbiol"},{"key":"pone.0235958.ref026","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/135965350901400313","article-title":"Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries","volume":"14","author":"AF Aghokeng","year":"2009","journal-title":"Antivir Ther"},{"key":"pone.0235958.ref027","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00705-011-0982-3","article-title":"Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon","volume":"156","author":"J Fokam","year":"2011","journal-title":"Arch Virol"},{"key":"pone.0235958.ref028","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95\/98NT. Nucl.Acids","volume":"41","author":"T A. Hall","year":"1999","journal-title":"SymP.Ser"},{"key":"pone.0235958.ref029","unstructured":"WHO. Surveillance of HIV Drug Resistance in Populations Initiating Antiretroviral Therapy (Pre-Treatment HIV Drug Resistance). 2014. http:\/\/apps.who.int\/iris\/bitstream\/10665\/112802\/1\/9789241507196_eng.pdf."},{"key":"pone.0235958.ref030","unstructured":"World Health Organisation: HIV Drug Resistance Report. ISBN 978 92 4150393 8 http:\/\/www.who.int\/hiv\/pub\/drugresistance\/report2012\/en\/index.html, accessed on 15 September 2012"},{"issue":"9","key":"pone.0235958.ref031","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/jac\/dky221","article-title":"Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey","volume":"73","author":"GF Tchouwa","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"pone.0235958.ref032","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/jac\/dkn234","article-title":"Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006","volume":"62","author":"A Derache","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"pone.0235958.ref033","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3329\/jhpn.v29i4.8444","article-title":"Prevalence of Antiretroviral Drug Resistance Mutations and HIV-1 Subtypes among Newly-diagnosed Drug-na\u00efve Persons Visiting a Voluntary Testing and Counselling Centre in Northeastern South Africa","volume":"29","author":"JM Nwobegahay","year":"2011","journal-title":"J Health Popul Nutr"},{"key":"pone.0235958.ref034","doi-asserted-by":"crossref","first-page":"e0171124","DOI":"10.1371\/journal.pone.0171124","article-title":"Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-na\u00efve persons in rural western Kenya","volume":"12","author":"H Onywera","year":"2017","journal-title":"PLOS ONE"},{"issue":"5","key":"pone.0235958.ref035","first-page":"380","article-title":"The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-na\u00efve (HIV1)- infected individuals in Casablanca, Morocco","volume":"3","author":"Khadija Bakhouch","year":"2009","journal-title":"J Infect Dev Ctries"},{"key":"pone.0235958.ref036","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.38665.534595.55","article-title":"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study","volume":"331","author":"UK Collaborative Group on HIV Drug Resistance","year":"2005","journal-title":"BMJ"},{"key":"pone.0235958.ref037","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/510748","article-title":"Clinical Utility of HIV Standard Genotyping among Antiretroviral Naive Individuals with Unknown Duration of Infection","volume":"44","author":"Davey Smith","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"pone.0235958.ref038","doi-asserted-by":"crossref","first-page":"105Y109","DOI":"10.1089\/088922204322749558","article-title":"Protease mutations in HIV-1 non-B strains infecting drug-naive villagers of Cameroon","volume":"20","author":"FA Konings","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0235958.ref039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.qai.0000226793.16216.55","article-title":"Emergence of Antiretroviral Therapy Resistance-Associated Primary Mutations Among Drug-Naive HIV-1YInfected Individuals in Rural Western Cameroon","volume":"43","author":"Y Koizumi","year":"2006","journal-title":"(J Acquir Immune Defic Syndr"},{"issue":"17","key":"pone.0235958.ref040","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/QAD.0b013e32834bbbe9","article-title":"Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients","volume":"25","author":"AF Aghokeng","year":"2011","journal-title":"AIDS"},{"issue":"2","key":"pone.0235958.ref041","doi-asserted-by":"crossref","first-page":"e0210559","DOI":"10.1371\/journal.pone.0210559","article-title":"Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya","volume":"14","author":"AS Hassan","year":"2019","journal-title":"PLOS ONE. 13 f\u00e9vr"},{"issue":"7","key":"pone.0235958.ref042","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/jac\/dky103","article-title":"Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015\u201316","volume":"73","author":"HA Mbunkah","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"pone.0235958.ref043","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/QAI.0b013e3182237f74","article-title":"Effect of mutations at position E138 in HIV-1 reverse transcriptase on phenotypic susceptibility and virologic response to etravirine","volume":"58","author":"L Tambuyzer","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0235958.ref044","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/aid.2015.0095","article-title":"Sub-epidemics explain localized high prevalence of reduced susceptibility to rilpivirine in treatment-naive HIV-1 infected patients: subtype and geographic compartmentalization of baseline resistance mutations","volume":"32","author":"K Theys","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0235958.ref045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jac\/dkt316","article-title":"Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing","volume":"69","author":"L George","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"pone.0235958.ref046","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jmv.10550","article-title":"Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure","volume":"72","author":"AG Marcelin","year":"2004","journal-title":"J Med Virol"},{"key":"pone.0235958.ref047","unstructured":"Parikh U, Koontz D, Hammond J. K65R: a multinucleoside resistance mutation of increasing prevalence exhibits bi-directional phenotypic antagonism with TAM. 12th International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications, Los Cabos, Mexico, 2003, Abstr. 136."},{"issue":"1","key":"pone.0235958.ref048","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/314560","article-title":"Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro","volume":"179","author":"MD Miller","year":"1999","journal-title":"J Infect Dis"},{"key":"pone.0235958.ref049","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJM199512213332502","article-title":"Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party","volume":"333","author":"JJ Eron","year":"1995","journal-title":"N Engl J Med"},{"key":"pone.0235958.ref050","doi-asserted-by":"crossref","first-page":"e72680","DOI":"10.1371\/journal.pone.0072680","article-title":"Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance","volume":"8","author":"SC Billong","year":"2013","journal-title":"PLOS ONE"},{"key":"pone.0235958.ref051","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-4690-3-40","article-title":"The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness","volume":"3","author":"HF Njai","year":"2006","journal-title":"Retrovirology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T16:25:34Z","timestamp":1667492734000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235958"}},"subtitle":[],"editor":[{"given":"Francesca","family":"Ceccherini-Silberstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235958","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]}}}